NYSE - Delayed Quote • USD
McKesson Corporation (MCK)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:34 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 15 | 9 | 18 | 18 |
Avg. Estimate | 6.34 | 7.15 | 27.6 | 31 |
Low Estimate | 6.2 | 6.86 | 27.31 | 30.07 |
High Estimate | 6.68 | 7.29 | 27.93 | 31.6 |
Year Ago EPS | 7.19 | 7.27 | 25.94 | 27.6 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 12 | 7 | 15 | 15 |
Avg. Estimate | 79.35B | 80.84B | 311.94B | 339.12B |
Low Estimate | 77.7B | 78.17B | 310.3B | 332.67B |
High Estimate | 81.12B | 82.67B | 313.71B | 357.25B |
Year Ago Sales | 68.91B | -- | 276.71B | 311.94B |
Sales Growth (year/est) | 15.10% | -- | 12.70% | 8.70% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 7.17 | 5.87 | 6.15 | 7.05 |
EPS Actual | 7.19 | 7.27 | 6.23 | 7.74 |
Difference | 0.02 | 1.4 | 0.08 | 0.69 |
Surprise % | 0.30% | 23.90% | 1.30% | 9.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 6.34 | 7.15 | 27.6 | 31 |
7 Days Ago | 6.34 | 7.15 | 27.6 | 31.01 |
30 Days Ago | 6.35 | 7.13 | 27.61 | 31.01 |
60 Days Ago | 6.35 | 7.13 | 27.6 | 30.99 |
90 Days Ago | 6.77 | 7.25 | 27.31 | 30.8 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 2 | 3 | 4 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
CURRENCY IN USD | MCK | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -11.80% | -- | -- | 6.50% |
Next Qtr. | -1.70% | -- | -- | 12.00% |
Current Year | 6.40% | -- | -- | 5.30% |
Next Year | 12.30% | -- | -- | 13.10% |
Next 5 Years (per annum) | 9.84% | -- | -- | 11.09% |
Past 5 Years (per annum) | 18.33% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 4/15/2024 |
Maintains | Argus Research: Buy to Buy | 4/10/2024 |
Maintains | UBS: Buy to Buy | 3/6/2024 |
Initiated | Leerink Partners: Outperform | 2/26/2024 |
Maintains | Mizuho: Neutral to Neutral | 2/9/2024 |
Maintains | Citigroup: Buy to Buy | 2/8/2024 |
Related Tickers
CAH Cardinal Health, Inc.
103.21
-0.58%
COR Cencora, Inc.
240.88
+0.47%
HSIC Henry Schein, Inc.
73.13
+0.43%
OMI Owens & Minor, Inc.
25.09
+4.02%
PDCO Patterson Companies, Inc.
25.77
-0.12%
ABG.BE AmerisourceBergen Corp
222.30
+1.25%
ZYXI Zynex, Inc.
11.21
+2.47%
ABC.VI Cencora, Inc.
224.25
-0.09%
COSM Cosmos Health Inc.
0.6500
+24.81%
ABG.F Cencora, Inc.
222.65
+1.78%